Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-663068 in Treatment-Experienced HIV-1
NCT01384734Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of fostemsavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Jul 2011; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01384734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384734.